We will design assay proposals and work with you to map out how best to ensure success. Our dedicated team from R&D, Quality and Regulatory Affairs delivering timely expert support.
Flat-fee milestone model
Milestone fee schedule aligned with drug development. R-Biopharm programs fully integrate with clinical development.
Partnership model for drugs under development
A complementary diagnostic test can be developed for already approved drugs. The assay provides guidance and optimizes the therapeutic use. This test can help to improve the health economic value proposition.